{
    "doi": "https://doi.org/10.1182/blood-2020-133039",
    "article_title": "Bioengineering Strategies to Phenotypically Define Minimal Residual Disease ",
    "article_date": "November 5, 2020",
    "session_type": ".Getting the Most from Minimal Residual Disease",
    "author_names": [
        "Scott R. Manalis, PhD"
    ],
    "author_dict_list": [
        {
            "author_name": "Scott R. Manalis, PhD",
            "author_affiliations": [
                "Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-20T15:35:12",
    "is_scraped": "1"
}